companydata.dkcompanydata.dk

ELDON BIOLOGICALS A/S: Financial statements 2021

CVR: 26747007

Source: annual report 2021, Danish Business Authority

01/07/202030/06/2021

ELDON BIOLOGICALS A/S (CVR 26747007) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 19,531,441 and a net result of DKK 9,098,419 compared with DKK 6,608,688 the year before. That is an increase of 36.3% compared with the year before. Equity in the 2021 report amounted to DKK 25,147,474. The solvency ratio was 77.7%. The company had 11 employees in the financial year.

Gross Profit
DKK 19,531,441
Profit/Loss
DKK 9,098,419
Equity
DKK 25,147,474
Total Assets
DKK 32,346,674
Employees
11

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2021-19.5 mio.9.1 mio.25.1 mio.11
2020-14.3 mio.6.6 mio.16.5 mio.8
2019-9.5 mio.3.3 mio.10.5 mio.6
2018-9.5 mio.3.8 mio.7.1 mio.7
2017-8 mio.2.6 mio.3.9 mio.7

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like ELDON BIOLOGICALS A/S

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

About ELDON BIOLOGICALS A/S

ELDON BIOLOGICALS A/S is a Danish company of the type Aktieselskab based in Gentofte, founded in 2002. The company is registered under the industry Fremstilling af andre kemiske produkter i.a.n.. The management consists of Kasper Juul Hedegaard. The board consists of Michael Lützhøft Hansen (chair), Cara Beth Seiderman and Kasper Juul Hedegaard. The company is owned by MEDI-TRADE ApS and HOLDINGSELSKABET MLH ApS. The company has 9 employees (2018). In 2025, the company reported a gross profit of DKK 13,635,058 and a net result of DKK 3,900,353 compared with DKK 6,673,643 the year before. Equity in the 2025 report amounted to DKK 42,055,949.

Source: annual report 2025, Danish Business Authority